Broadfin Capital, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.

Quarter-by-quarter ownership
Broadfin Capital, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$2,109,000
-42.5%
89,730
-54.7%
0.28%
-58.4%
Q3 2019$3,667,000
-74.0%
198,237
-73.8%
0.68%
-77.9%
Q2 2019$14,091,000
-5.2%
757,998
+24.7%
3.06%
-0.1%
Q1 2019$14,859,000
+380.3%
607,998
+409.7%
3.07%
+654.1%
Q4 2018$3,094,000
-75.0%
119,294
-69.5%
0.41%
-77.7%
Q3 2018$12,382,000
-48.6%
391,213
-36.9%
1.82%
-51.9%
Q2 2018$24,079,000
-44.8%
619,787
-60.8%
3.79%
-44.3%
Q1 2018$43,647,000
+18.9%
1,581,416
-22.0%
6.80%
+13.3%
Q4 2017$36,716,000
-34.2%
2,028,518
-41.3%
6.00%
-27.3%
Q3 2017$55,810,000
-14.6%
3,455,710
-26.8%
8.26%
+4.0%
Q2 2017$65,361,000
-11.9%
4,719,259
-4.6%
7.94%
-11.7%
Q1 2017$74,211,000
+45.3%
4,947,403
+26.9%
8.99%
+58.5%
Q4 2016$51,085,000
-5.9%
3,899,587
+23.8%
5.67%
+16.6%
Q3 2016$54,274,000
+140.5%
3,150,000
+152.0%
4.86%
+121.7%
Q2 2016$22,564,000
-18.9%
1,250,104
-14.7%
2.19%
-18.4%
Q1 2016$27,829,000
-53.3%
1,465,475
-34.3%
2.69%
-26.7%
Q4 2015$59,594,000
+3.4%
2,232,001
-5.5%
3.66%
+14.3%
Q3 2015$57,633,000
-22.8%
2,362,001
-1.4%
3.21%
-20.1%
Q2 2015$74,681,000
+82.8%
2,396,681
-14.7%
4.01%
+26.1%
Q1 2015$40,859,000
-27.7%
2,808,173
-50.0%
3.18%
+29.6%
Q4 2014$56,500,000
+141.5%
5,616,346
+100.0%
2.46%
+0.1%
Q3 2014$23,392,000
-66.2%
2,808,173
-50.0%
2.45%
-28.0%
Q2 2014$69,194,000
+122.8%
5,616,346
+151.5%
3.40%
+13.2%
Q1 2014$31,063,0002,233,1733.01%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders